Cancer Translational Medicine

REVIEW
Year
: 2019  |  Volume : 5  |  Issue : 3  |  Page : 56--59

Advances on the components of fibrinolytic system in malignant tumors


Zengzheng Ge1, Xiaoyan Xu1, Zengyu Ge2, Shaopeng Zhou3, Xiulin Li1, Kai Yao1, Lan Deng4 
1 Department of Clinical Medicine, The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
2 Department of Nursing, School of Nursing, Hubei Polytechnic Institute, Huangshi, China
3 Department of Medical Imagin, The First School of Clinical Medicine, Southern Medical University, Guangzhou, China
4 Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China

Correspondence Address:
Dr. Lan Deng
Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong Province
China

The major function of fibrinolytic system is to dissolve the fibrins formed by blood coagulation and maintain the balance between blood coagulation and thrombolysis, which plays an important role in maintaining the liquid state of the blood and unclogging the blood vessels. It is a serious problem that malignant tumor does great harm to human life and health. In recent years, more and more studies signified that the fibrinolytic system in malignant tumors, especially adenocarcinoma, plays a major role in its progression, which indicates that the fibrinolytic system is of great significance in the development of malignant tumors. Besides, the fibrinolytic system has also gradually been known and used to diagnose and treat the adenocarcinoma. This article reviews how the fibrinolytic system works in the occurrence of malignant tumor and summarizes the diagnostic method and treatment of adenocarcinoma according to the latest clinical research progress, laying the foundation for further research.


How to cite this article:
Ge Z, Xu X, Ge Z, Zhou S, Li X, Yao K, Deng L. Advances on the components of fibrinolytic system in malignant tumors.Cancer Transl Med 2019;5:56-59


How to cite this URL:
Ge Z, Xu X, Ge Z, Zhou S, Li X, Yao K, Deng L. Advances on the components of fibrinolytic system in malignant tumors. Cancer Transl Med [serial online] 2019 [cited 2020 Oct 31 ];5:56-59
Available from: http://www.cancertm.com/article.asp?issn=2395-3977;year=2019;volume=5;issue=3;spage=56;epage=59;aulast=Ge;type=0